Tags

Type your tag names separated by a space and hit enter

[Study on mesh-augmented vaginal reconstructive surgery in treatment of pelvic organ prolapse].
Zhonghua Fu Chan Ke Za Zhi. 2011 Feb; 46(2):101-4.ZF

Abstract

OBJECTIVE

To evaluate clinical outcome and complications of mesh-augmented vaginal reconstructive surgery in treatment of pelvic organ prolapse.

METHODS

From Feb 2007 to Jan 2009, mesh-augmented vaginal reconstructive surgery were performed on 66 women with pelvic organ prolapse stage III-IV. Pre and postoperative symptoms, pelvic organ prolapse quantitation (POP-Q) stage and pelvic floor distress inventory-short form 20 (PFDI-20) measurements were studied to assess anatomic and quality-of-life outcome. Operative complications were also analyzed.

RESULTS

Totally 65 patients underwent successful surgeries. The rate of follow-up was 97% (63/65) with a median follow-up of 17.2 months. Subjective cure rate and objective cure rate were both 97% (61/63) at 6 and 12 months after surgeries, 51 women completed PFDI-20 measurements and scores were 102 ± 50 before surgery, 16 ± 21 at 6 months and 15 ± 20 at 12 months. It reached statistical difference when scores were compared before and after surgeries (P < 0.05). Among 66 patients, 2 patients underwent organ injuries, 2 had recurrent prolapse, 4 had mesh-related complications and 1 had severe de novo stress urinary incontinence. Six patients underwent second surgery.

CONCLUSIONS

Mesh-augmented vaginal reconstructive surgery in treatment of pelvic organ prolapsed brought satisfied clinical outcome. The incidence of mesh-related complications was low and secondary operative interventions were effective.

Links

Publisher Full Text

Authors+Show Affiliations

Han JS
Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China. Email: hanjinsong353@sina.com.
Zhang K
No affiliation info available
Zhu FL
No affiliation info available
Yao Y
No affiliation info available
Liang HM
No affiliation info available
Zhou LF
No affiliation info available
Guo HY
No affiliation info available

MeSH

AgedAged, 80 and overFemaleFollow-Up StudiesGynecologic Surgical ProceduresHumansHysterectomy, VaginalIntraoperative ComplicationsMiddle AgedPelvic Organ ProlapsePolypropylenesPostoperative ComplicationsQuality of LifeRecurrenceSeverity of Illness IndexSurgical MeshSurveys and QuestionnairesTreatment OutcomeUterine ProlapseUterusVagina

Pub Type(s)

English Abstract
Journal Article
Research Support, Non-U.S. Gov't

Language

chi

PubMed ID

21426766

Citation

Han, Jin-song, et al. "[Study On Mesh-augmented Vaginal Reconstructive Surgery in Treatment of Pelvic Organ Prolapse]." Zhonghua Fu Chan Ke Za Zhi, vol. 46, no. 2, 2011, pp. 101-4.
Han JS, Zhang K, Zhu FL, et al. [Study on mesh-augmented vaginal reconstructive surgery in treatment of pelvic organ prolapse]. Zhonghua Fu Chan Ke Za Zhi. 2011;46(2):101-4.
Han, J. S., Zhang, K., Zhu, F. L., Yao, Y., Liang, H. M., Zhou, L. F., & Guo, H. Y. (2011). [Study on mesh-augmented vaginal reconstructive surgery in treatment of pelvic organ prolapse]. Zhonghua Fu Chan Ke Za Zhi, 46(2), 101-4.
Han JS, et al. [Study On Mesh-augmented Vaginal Reconstructive Surgery in Treatment of Pelvic Organ Prolapse]. Zhonghua Fu Chan Ke Za Zhi. 2011;46(2):101-4. PubMed PMID: 21426766.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Study on mesh-augmented vaginal reconstructive surgery in treatment of pelvic organ prolapse]. AU - Han,Jin-song, AU - Zhang,Kun, AU - Zhu,Fu-li, AU - Yao,Ying, AU - Liang,Hua-mao, AU - Zhou,Li-fei, AU - Guo,Hong-yan, PY - 2011/3/24/entrez PY - 2011/3/24/pubmed PY - 2012/1/20/medline SP - 101 EP - 4 JF - Zhonghua fu chan ke za zhi JO - Zhonghua Fu Chan Ke Za Zhi VL - 46 IS - 2 N2 - OBJECTIVE: To evaluate clinical outcome and complications of mesh-augmented vaginal reconstructive surgery in treatment of pelvic organ prolapse. METHODS: From Feb 2007 to Jan 2009, mesh-augmented vaginal reconstructive surgery were performed on 66 women with pelvic organ prolapse stage III-IV. Pre and postoperative symptoms, pelvic organ prolapse quantitation (POP-Q) stage and pelvic floor distress inventory-short form 20 (PFDI-20) measurements were studied to assess anatomic and quality-of-life outcome. Operative complications were also analyzed. RESULTS: Totally 65 patients underwent successful surgeries. The rate of follow-up was 97% (63/65) with a median follow-up of 17.2 months. Subjective cure rate and objective cure rate were both 97% (61/63) at 6 and 12 months after surgeries, 51 women completed PFDI-20 measurements and scores were 102 ± 50 before surgery, 16 ± 21 at 6 months and 15 ± 20 at 12 months. It reached statistical difference when scores were compared before and after surgeries (P < 0.05). Among 66 patients, 2 patients underwent organ injuries, 2 had recurrent prolapse, 4 had mesh-related complications and 1 had severe de novo stress urinary incontinence. Six patients underwent second surgery. CONCLUSIONS: Mesh-augmented vaginal reconstructive surgery in treatment of pelvic organ prolapsed brought satisfied clinical outcome. The incidence of mesh-related complications was low and secondary operative interventions were effective. SN - 0529-567X UR - https://www.unboundmedicine.com/medline/citation/21426766/[Study_on_mesh_augmented_vaginal_reconstructive_surgery_in_treatment_of_pelvic_organ_prolapse]_ L2 - http://journal.yiigle.com/LinkIn.do?linkin_type=pubmed&amp;issn=0529-567X&amp;year=2011&amp;vol=46&amp;issue=2&amp;fpage=101 DB - PRIME DP - Unbound Medicine ER -